Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Cash & Current Investments (2018 - 2025)

Historic Cash & Current Investments for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $44.9 million.

  • Precision Biosciences' Cash & Current Investments fell 5566.29% to $44.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.9 million, marking a year-over-year decrease of 5566.29%. This contributed to the annual value of $86.3 million for FY2024, which is 2602.55% down from last year.
  • As of Q3 2025, Precision Biosciences' Cash & Current Investments stood at $44.9 million, which was down 5566.29% from $62.2 million recorded in Q2 2025.
  • Precision Biosciences' Cash & Current Investments' 5-year high stood at $212.1 million during Q3 2022, with a 5-year trough of $44.9 million in Q3 2025.
  • In the last 5 years, Precision Biosciences' Cash & Current Investments had a median value of $137.8 million in 2024 and averaged $133.8 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 5998.46% in 2021, then plummeted by 5566.29% in 2025.
  • Precision Biosciences' Cash & Current Investments (Quarter) stood at $143.7 million in 2021, then skyrocketed by 31.96% to $189.6 million in 2022, then crashed by 38.45% to $116.7 million in 2023, then decreased by 26.03% to $86.3 million in 2024, then tumbled by 48.01% to $44.9 million in 2025.
  • Its Cash & Current Investments stands at $44.9 million for Q3 2025, versus $62.2 million for Q2 2025 and $77.2 million for Q1 2025.